Pfizer
PFE
2,244 hedge funds and large institutions have $154B invested in Pfizer in 2017 Q4 according to their latest regulatory filings, with 283 funds opening new positions, 859 increasing their positions, 864 reducing their positions, and 59 closing their positions.
380% more first-time investments, than exits
New positions opened: 283 | Existing positions closed: 59
10% more funds holding
Funds holding: 2,040 → 2,244 (+204)
2% more capital invested
Capital invested by funds: $151B → $154B (+$3.3B)
0.43% more ownership
Funds ownership: 75.05% → 75.48% (+0.43%)
1% less repeat investments, than reductions
Existing positions increased: 859 | Existing positions reduced: 864
8% less funds holding in top 10
Funds holding in top 10: 177 → 163 (-14)
27% less call options, than puts
Call options by funds: $937M | Put options by funds: $1.28B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$438M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$411M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$308M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$287M |
| 5 |
Bank of New York Mellon
New York
|
+$271M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$590M |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
-$434M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$261M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$242M |
| 5 |
Renaissance Technologies
New York
|
-$166M |
PFE Hedge Fund Activity: Q4 2017 in Review
2,244 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2017, worth a combined $154B — up 2.2% from $151B a quarter earlier.
Buyers outnumbered sellers: 283 funds opened new PFE positions and 59 closed out — a net gain of 224 holders — while 859 added to existing stakes and 864 trimmed.
The largest buyer was BlackRock, adding an estimated $438M. The largest seller was Bank of America, cutting an estimated $590M.
- 2,244 institutional investors held Pfizer (PFE) as of Q4 2017, up from 2,040 in Q3 2017.
- Funds reported $154B of Pfizer stock for Q4 2017, up 2.2% quarter-over-quarter.
- 283 funds opened new Pfizer positions in Q4 2017 and 59 closed out, a net change of +224 holders.
- The largest Pfizer buyer in Q4 2017 was BlackRock, an estimated $438M added.
- The largest Pfizer seller in Q4 2017 was Bank of America, an estimated $590M sold.
Based on aggregated 13F filings for Q4 2017.